Use of a deep learning application to classify recommendations made by hospital pharmacists during medication prescription review

Author:

Alkanj Ahmad1,Godet Julien2,Johns Erin1,Gourieux Bénédicte3,Michel Bruno3ORCID

Affiliation:

1. Centre de recherche en biomédecine: Centre de recherche en biomedecine

2. Strasbourg University Hospitals: Les Hopitaux Universitaires de Strasbourg

3. Hôpitaux universitaires de Strasbourg: Les Hopitaux Universitaires de Strasbourg

Abstract

Abstract Background Recommendations are proposals made by hospital pharmacists to address the sub-optimal use of medications during prescription review. Objective To perform a large-scale descriptive analysis of recommendations formulated during prescription review using a deep neural network classifier in a hospital Setting This retrospective study was conducted at the University Hospital of Strasbourg. Main outcome measures Recommendations were automatically classified according to the coding of the French Society of Clinical Pharmacy. Method Data from 2018 to 2020 were collected from prescription support software. Results 2,930,656 prescription lines were analysed for a total of 119,689 patients. Among these prescription lines, 153,335 resulted in recommendations (n = 48,202 patients). Recommendations were predominantly observed in patients aged 65 years or older (n=26,141 patients) and in patients taking 5 or more medications (44,702). The most frequently identified types of Drug-related problems associated with recommendations were “Non conformity to guidelines or contra-indication” (n =88,523; 57.7%), “Overdosage” (16,975; 11.1%) and “Improper administration” (13, 898; 9.1%). The most frequently encountered drugs were: Paracetamol (n= 10,585; 6.9%), Esomeprazole (6,031; 3.9%), Hydrochlorothiazide (2,951; 1.9%), Enoxaparin (2,191; 1.4%), Tramadol (1,879; 1.2%), Calcium (2, 073; 1.3%), Perindopril (1,950; 1.2%), Amlodipine (1,716; 1.1%), Simvastatin (1,560; 1.0%) and Insulin (1,019; 0.7%). Conclusion The deep neural network classifier used met the challenge of automatically classifying recommendations from a large database without mobilizing significant human resources. The use of such a classifier can lead to alerting caregivers about certain risky attitudes in prescription and administration, and triggering actions to improve practices.

Publisher

Research Square Platform LLC

Reference25 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3